Draegerwerk Ag & Co. Kgaa · XETR:DRW8

Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — Q1 2020 Earnings Presentation

14 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Apr 30, 2020

  1. Slide 1: Q1 Conference Call

    Q1 Conference Call Drägerwerk AG & Co. KGaA Lübeck, April 30, 2020

  2. Slide 2: Disclaimer

    Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d

  3. Slide 3: Business Highlights Q1

    Business Highlights Q1  Corona pandemic boosts order entry for intensive care medical products as well as light breathing protection  Production ramp-up to meet increased Corona demand  Launch of new Evita ventilators  FDA Warning Letter – work in progress  Termination of the participation cert

  4. Slide 4: Order Development in Q1

    Order Development in Q1 Order entry (€ million) Group Americas Europe AAA Net Sales + 2.9% + 48.2% + 9.3% Safety 350 +32% +5.7% Medical 1,043 +177% + 91.8% + 262.4% + 95.0% +8.0% Group 1,393 +117% + 58.3% + 163.2% + 65.2% +7.1% Growth rates are net of currency effects 4

  5. Slide 5: Business development Group

    Business development Group Net Sales Order entry Q1 2019 Q1 2020 fx-adj. +7.1% Europa 348.9 915.6 +163.2 Currency Americas 121.8 189.7 +58.3 adjusted AAA 176.9 287.4 +65.2 +6.4% nominal Group 647.6 1,392.7 +116.7 640 602  Very strong order entry in Q1: +116.7% (nominal: +115.1%)  Higher quarterly

  6. Slide 6: Business development Medical

    Business development Medical Net Sales Order entry Q1 2019 Q1 2020 fx-adj. +8.0% Europa 187.3 678.0 +262.4 Currency adjusted Americas 75.8 143.0 +91.8 +7.4% AAA 115.4 222.1 +95.0 nominal 396 Medical 378.5 1043.1 +177.2 368  COVID 19 drives exceptional high demand for ventilators. Strong demand Q1'1

  7. Slide 7: Business development Safety

    Business development Safety Net Sales Order entry Q1 2019 Q1 2020 fx-adj. +5.7% Europa 161.6 237.6 +48.2 Currency adjusted Americas 46.0 46.7 +2.9 +4.8% AAA 61.5 65.3 +9.3 nominal Safety 269.0 349.6 +31.6 233 244  The demand for light breathing protection (FFP masks) has risen sharply, Q1'19 Q1'20

  8. Slide 8: Key figures

    Key figures Q1 2019 Q1 2020 Change € million € million % Cashflow from operating activities 23.3 49.4 > +100.0 Investments 19.3 27.0 40.3 1 Cash and cash equivalents 158.6 216.1 36.2 1 Net financial debt 136.6 358.7 > +100.0 Net financial debt 1 /EBITDA 2 0.74 1.75 Capital employed 1 1,424.9 1,377.0

  9. Slide 9: Termination of the participation certificates and equity increase

    Termination of the participation certificates and equity increase March:  Cancellation of PC series D  # 566,819 pc @ termination price EUR 546.20  Termination value EUR 310 million, due Jan. 2023 Equity ratio ~29% (pro forma as of March, 2020 and incl. termination series A / K and capital increa

  10. Slide 10: Outlook 2020

    Outlook 2020 Guidance withdrawn: The former guidance does not include the business impact from COVID 19. The forecast will be renewed in Q2 2020! EXPECTATIONS FOR FISCAL YEAR 2020 2019 2020e + 5.9% +1.0 - +4.0 % Net sales (net of currency effects) (net of currency effects) EBIT margin 2.4% 1.0 - 4.0

  11. Slide 11: Questions & Answers

    Questions & Answers Drägerwerk AG & Co. KGaA

  12. Slide 12: Financial calendar

    Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. - March 5, 2020 Final 2019 figures Conference call - April 30, 2020 Report for the first three months 2020 Conferen

  13. Slide 13: Contact

    Contact Melanie Kamann Thomas Fischler Corporate Communications Investor Relations Drägerwerk AG & Co. KGaA Drägerwerk AG & Co. KGaA Moislinger Allee 53−55 Moislinger Allee 53−55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel +49 451 882-3998 Tel +49 451 882-2685 Fax +49 451 882-3944 Fax +49 451 88

  14. Slide 14: Thank you

    Thank you Drägerwerk AG & Co. KGaA 14

Drägerwerk AG & Co. KGaA — Q1 2020 Earnings Presentation on 6ix